News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Daily News PCR London Valves 2021 Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves Michael O'Riordan December 01, 2021
News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Conference News PCR London Valves 2021 MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND Shelley Wood November 26, 2021
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Conference News PCR London Valves 2021 Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry Shelley Wood November 24, 2021
News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim Caitlin E. Cox November 24, 2021
News Daily News US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access L.A. McKeown November 23, 2021
News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021